KUMAMOTO University

R

研究実績RESEARCH ACHIEVEMENTS

  1. Utsunomiya M, Dobashi H, Odani T, Saito K, Yokogawa N, Nagasaka K, Takenaka K, Soejima M, Sugihara T, Hagiyama H,Hirata S, Matsui K, Nonomura Y, Kondo M, Suzuki F, Nawata Y, Tomita M, Kihara M, Yokoyama-Kokuryo W, Hirano F, Yamazaki H, Sakai R, Nanki T, Koike R, Miyasaka N, Harigai M.

    An open-label, randomized controlled trial of sulfamethoxazole-trimethoprim for Pneumocystis prophylaxis: results of 52-week follow-up.

    Rheumatol Adv Pract 4(2):rkaa029,2020.  doi: 10.1093/rap/rkaa029. eCollection 2020

    https://pubmed.ncbi.nlm.nih.gov/33134810/

     

     

  2. Kondo Y, Suzuki K, Inoue Y, Sakata K, Takahashi C, Kaneko Y, Takeuchi T.

    Safety and tolerability of ultrasound-guided synovial needle biopsy in Japanese arthritis patients.

    Mod Rheumatol Online ahead of print. 20:1-9,2020. doi: 10.1080/14397595.2020.1847754.

    https://pubmed.ncbi.nlm.nih.gov/33155872/

     

     

  3. Nishimura N, Endo S, Kawano Y,

    Myeloma Mouse Models in Studying Myeloma Associated Bone Disease.

    Reference Module in Biomedical Sciences. 2019 (in press)

    https://www.sciencedirect.com/science/article/pii/B9780128012383112486?via%3Dihub

     

  4. Kusumoto S, Tanaka Y, Suzuki R, Watanabe T, Nakata M, Sakai R, Fukushima N, Fukushima T, Moriuchi Y, Itoh K, Nosaka K, Choi I, Sawa M, Okamoto R, Tsujimura H, Uchida T, Suzuki S, Okamoto M, Takahashi T, Sugiura I, Onishi Y, Kohri M, Yoshida S, Kojima M, Takahashi H, Tomita A, Atsuta Y, Maruyama D, Tanaka E, Suzuki T, Kinoshita T, Ogura M, Ueda R and Mizokami M.

    Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma.

    J Hepatol 73(2):285-293,2020.  doi: 10.1016/j.jhep.2020.03.009. Epub 2020 Mar 17.

    https://pubmed.ncbi.nlm.nih.gov/32194183/

     

  5. Hashiguchi Y, Oda K, Katanoda T, Nosaka K, Jono H and Saito H

    Clinical evaluation of cefotiam in the treatment of bacteremia caused by Escherichia coli, Klebsiella species, and Proteus mirabilis: A retrospective study.

    J Infect Chemother 26(11):1158-1163. doi: 10.1016/j.jiac.2020.06.007. Epub 2020 Aug 20.

    https://pubmed.ncbi.nlm.nih.gov/32828676/

     

  6. Nishimura N, Endo S, Kawano Y.

    Myeloma Mouse Models in Studying Myeloma Associated Bone Disease.

    Encyclopedia of Bone Biology 3:355-361,2020.

     

     

     

  7. Okuma K, Kuramitsu M, Niwa T, Taniguchi T, Masaki Y, Ueda G, Matsumoto C, Sobata R, Sagara Y, Nakamura H, Satake M, Miura K, Fuchi N, Masuzaki H, Okayama A, Umeki K, Yamano Y, Sato T, Iwanaga M, Uchimaru K, Nakashima M, Utsunomiya A, Kubota R, Ishitsuka K, Hasegawa H, Sasaki D, Koh KR, Taki M, Nosaka K, Ogata M, Naruse I, Kaneko N, Okajima S, Tezuka K, Ikebe E, Matsuoka S, Itabashi K, Saito S, Watanabe T and Hamaguchi I

    Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.

    Retrovirology 17(1):26, 2020. doi: 10.1186/s12977-020-00534-0.

    https://pubmed.ncbi.nlm.nih.gov/32831150/

     

     

  8. Tanaka A, Ishitsuka Y, Ohta H, Fujimoto A, Yasunaga JI, Matsuoka M.

    Systematic clustering algorithm for chromatin accessibility data and its application to hematopoietic cells.

    PLOS Comput Biol 16(11):e1008422. doi: 10.1371/journal.pcbi.1008422. eCollection 2020 Nov.

    https://pubmed.ncbi.nlm.nih.gov/33253153/

     

  9. Cui G, Shimba A, Ma G, Takahara K, Tani-Ichi S, Zhu Y, Asahi T, Abe A, Miyachi H, Kitano S, Hara T, Yasunaga JI, Suwanai H, Yamada H, Matsuoka M, Ueki K, Yoshikai Y, Ikuta K.

    IL-7R-Dependent Phosphatidylinositol 3-Kinase Competes with the STAT5 Signal to Modulate T Cell Development and Homeostasis.

    J Immunol. 2020 Feb 15;204(4):844-857. doi: 10.4049/jimmunol.1900456. Epub 2020 Jan 10.

    https://pubmed.ncbi.nlm.nih.gov/31924648/

     

  10. Shimoda K, Takahashi N, Kirito K, Iriyama N, Kawaguchi T, Kizaki M

    JSH Practical Guidelines for Hematological Malignancies, 2018: I. Leukemia-4. Chronic myeloid leukemia (CML)/myeloproliferative neoplasms (MPN).

    Int J Hematol 112 (3): 268-291,2020. doi: 10.1007/s12185-020-02964-0. Epub 2020 Aug 11.

    https://pubmed.ncbi.nlm.nih.gov/32783166/

     

  11. Sato E, Iriyama N, Tokuhira M, Takaku T, Ishikawa M, Nakazato T, Sugimoto KJ, Fujita H, Kimura Y, Fujioka I, Asou N, Komatsu N, Kizaki M, Hatta Y, Kawaguchi T.

    The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort.

    Cancer Med 9(23): 8931-8939,2020. doi: 10.1002/cam4.3516. Epub 2020 Oct 10.

    https://pubmed.ncbi.nlm.nih.gov/33037866/

     

  12. Shichijo T, Fuji S, Nagler A, Bazarbachi A, Mohty M, Savani BN.

    Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?

    Bone Marrow Transplant 55(3): 505-522,2020.doi: 10.1038/s41409-019-0643-9. Epub 2019 Aug 21.

    https://pubmed.ncbi.nlm.nih.gov/31435032/

     

  13. Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Shiibashi R, Izutsu K.

    A multicenter, open-label, phase II study of tirabrutinib (ONO/GS-4059) in patients with Waldenström’s macroglobulinemia.

    Cancer Sci 111(9):3327-3337,2020. doi: 10.1111/cas.14561. Epub 2020 Jul 20.

    https://pubmed.ncbi.nlm.nih.gov/32639651/

     

  14. Shichijo T, Maruyama D, Yamauchi N, Maeshima AM, Sugano M, Yuda S, Tajima K, Kurihara H, Shimada K, Suzuki T, Toyoda K, Makita S, Fukuhara S, Munakata W, Suzuki T, Kobayashi Y, Taniguchi H, Minami Y, Izutsu K and Tobinai K.

    Transformation Scoring System (TSS): A new assessment index for clinical transformation of follicular lymphoma.

    Cancer Med 9(23): 8864-8874. doi: 10.1002/cam4.3501. Epub 2020 Oct 6.

    https://pubmed.ncbi.nlm.nih.gov/33022120/

     

  15. Fuji S, Kurosawa S, Inamoto Y, Murata T, Utsunomiya A, Uchimaru K, Yamasaki S, Inoue Y, Moriuchi Y, Choi I, Ogata M, Hidaka M, Yamaguchi T, Fukuda T.

    A decision analysis comparing unrelated bone marrow transplantation and cord blood transplantation in patients with aggressive adult T-cell leukemia-lymphoma.

    Int J Hematol 111(3):427-433,2020. doi: 10.1007/s12185-019-02777-w. Epub 2019 Nov 7.

    https://pubmed.ncbi.nlm.nih.gov/31701480/

     

  16. Nakamura T, Nakamura T, Amano M, Miyakawa T, Yamagata Y, Matsuoka M, Nakata H.
    A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor.
    J Virol. 2020 Sep 15;94(19):e00486-20. doi: 10.1128/JVI.00486-20. PMID: 32611758; PMCID: PMC7495394

  17. Sakata K, Yasuoka H, Yoshimoto K, Takeuchi T.

    Refractory IgG4-related Pleural Disease with Chylothorax: A Case Report and Literature Review.

    Intern Med Online ahead of print,2021.  doi: 10.1093/rheumatology/keaa312.

    https://pubmed.ncbi.nlm.nih.gov/32743653/

     

  18. Maeda M, Tanabe-Shibuya J, Miyazato P, Masutani H, Yasunaga JI, Usami K, Shimizu A, Matsuoka M.

    IL-2/IL-2 Receptor Pathway Plays a Crucial Role in the Growth and Malignant Transformation of HTLV-1-Infected T Cells to Develop Adult T-Cell Leukemia.

    Front Microbiol. 2020 Mar 6;11:356. doi: 10.3389/fmicb.2020.00356. eCollection 2020.

    https://pubmed.ncbi.nlm.nih.gov/32210945/

     

  19. Oda K, Jono H, Nosaka K and Saito H.

    Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15-20 μg/mL concentration.

    Int J Antimicrob Agents 56: 106109,2020. doi: 10.1016/j.ijantimicag.2020.106109.

    https://pubmed.ncbi.nlm.nih.gov/32721597/

     

  20. Oda K, Miyakawa T, Katanoda T, Hashiguchi Y, Iwamura K, Nosaka K, Yamaguchi A, Jono H and Saito H.

    A case of recovery from aphasia following dose reduction of cefepime by bayesian prediction-based therapeutic drug monitoring.

    J Infect Chemother 26(5):498-501,2020. doi: 10.1016/j.jiac.2019.10.006. Epub 2020 Mar 4.

    https://pubmed.ncbi.nlm.nih.gov/32143960/

     

  21. Kagami Y, Yamamoto K, Shibata T, Tobinai K, Imaizumi Y, Uchida T, Shimada K, Minauchi K, Fukuhara N, Kobayashi H, Yamauchi N, Tsujimura H, Hangaishi A, Tominaga R, Suehiro Y, Yoshida S, Inoue Y, Suzuki S, Tokuhira M, Kusumoto S, Kuroda J, Yakushijin Y, Takamatsu Y, KubotaY, Nosaka K, Morishima S, Nakamura S, Ogura M, Maruyama D, Hotta T, Morishima Y, Tsukasaki K, Nagai H.

    R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma:JCOG0908 study.

    Cancer Sci 111(10):3770-3779,2020. doi: 10.1111/cas.14604. Epub 2020 Sep 11.

    https://pubmed.ncbi.nlm.nih.gov/32767806/

     

  22. Oda K, Katonoda T, Hashiguchi Y, Kondo S, Narita Y, Iwamura K, Nosaka K, Jono H and Saito H.

    Development and evaluation of a vancomycin dosing nomogram to achieve the target area under the concentration-time curve. A retrospective study.

    J Infect Chemother 26(5):444-450,2020. doi: 10.1016/j.jiac.2019.11.009. Epub 2019 Dec 24.

    https://pubmed.ncbi.nlm.nih.gov/31879186/

     

  23. Yanagawa Y, Shimogawara R, Endo T, Fukushima R, Gatanaga H, Hayasaka K, Kikuchi Y, Kobayashi T, Koga M, Koibuchi T, Miyagawa T, Nagata A, Nakata H, Oka S, Otsuka R, Sakai K, Shibuya M, Shingyochi H, Tsuchihashi E, Watanabe K, Yagita K.

    Utility of the Rapid Antigen Detection Test E. histolytica Quik Chek for the Diagnosis of Entamoeba histolytica Infection in Nonendemic Situations.

    J Clin Microbiol 58(11):e01991-20,2020. doi: 10.1128/JCM.01991-20. Print 2020 Oct 21.

    https://pubmed.ncbi.nlm.nih.gov/32878955/

     

  24. Ghosh AK, Kovela S, Osswald HL, Amano M, Aoki M, Agniswamy J, Wang YF, Weber IT, Mitsuya H.
    Structure-Based Design of Highly Potent HIV-1 Protease Inhibitors Containing New Tricyclic Ring P2-Ligands: Design, Synthesis, Biological, and X-ray Structural Studies.
    J Med Chem. 2020 May 14;63(9):4867-4879. doi: 10.1021/acs.jmedchem.0c00202. PMID: 32348139; PMCID: PMC7425579

CONTACT US

C

  • 患者様へ

    外来診療の方は外来予約センターより
    ご予約をお願いいたします。
    外来予約センター

  • 学生・研修医・医療関係者の方へ

    TEL
    096-373-5156
    FAX
    096-373-5158
    Mail
    nikyo*kumamoto-u.ac.jp
    (*はアットマーク)
Copyright 2019 KUMAMOTO University HRI All Rights Reserved.